Cargando…
Erratum to pembrolizumab-induced myocarditis in a patient with malignant mesothelioma: plasma exchange as a successful emerging therapy—case report
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264349/ https://www.ncbi.nlm.nih.gov/pubmed/34295695 http://dx.doi.org/10.21037/tlcr-2021-3 |
| _version_ | 1783719535846621184 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8264349 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82643492021-07-21 Erratum to pembrolizumab-induced myocarditis in a patient with malignant mesothelioma: plasma exchange as a successful emerging therapy—case report Transl Lung Cancer Res Erratum AME Publishing Company 2021-06 /pmc/articles/PMC8264349/ /pubmed/34295695 http://dx.doi.org/10.21037/tlcr-2021-3 Text en 2021 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Erratum Erratum to pembrolizumab-induced myocarditis in a patient with malignant mesothelioma: plasma exchange as a successful emerging therapy—case report |
| title | Erratum to pembrolizumab-induced myocarditis in a patient with malignant mesothelioma: plasma exchange as a successful emerging therapy—case report |
| title_full | Erratum to pembrolizumab-induced myocarditis in a patient with malignant mesothelioma: plasma exchange as a successful emerging therapy—case report |
| title_fullStr | Erratum to pembrolizumab-induced myocarditis in a patient with malignant mesothelioma: plasma exchange as a successful emerging therapy—case report |
| title_full_unstemmed | Erratum to pembrolizumab-induced myocarditis in a patient with malignant mesothelioma: plasma exchange as a successful emerging therapy—case report |
| title_short | Erratum to pembrolizumab-induced myocarditis in a patient with malignant mesothelioma: plasma exchange as a successful emerging therapy—case report |
| title_sort | erratum to pembrolizumab-induced myocarditis in a patient with malignant mesothelioma: plasma exchange as a successful emerging therapy—case report |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264349/ https://www.ncbi.nlm.nih.gov/pubmed/34295695 http://dx.doi.org/10.21037/tlcr-2021-3 |
| work_keys_str_mv | AT erratumtopembrolizumabinducedmyocarditisinapatientwithmalignantmesotheliomaplasmaexchangeasasuccessfulemergingtherapycasereport |